Quarterly report pursuant to Section 13 or 15(d)

INTANGIBLES (Tables)

v3.23.1
INTANGIBLES (Tables)
3 Months Ended
Mar. 31, 2023
INTANGIBLES  
Schedule of intangible assets

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

    

March 31, 2023

​

​

Estimated

​

​

​

​

​

​

​

​

​

​

​

Useful 

​

Gross

​

​

​

​

​

​

​

​

Lives

​

Carrying

​

Accumulated

​

Intangible

($’s in thousands)

    

(Years)

    

Value

    

Amortization

    

Assets, Net

Amortizable intangible assets:

​

  

​

​

  

​

​

  

​

​

​

  

Ceracade®

​

​

3

​

$

300

​

$

(300)

​

$

—

Luxamend®

 

​

3

 

​

50

 

​

(50)

​

 

—

Targadox®

 

​

3

 

​

1,250

 

​

(1,250)

​

 

—

Ximino®

 

​

7

 

​

7,134

 

​

(3,737)

​

 

3,397

Exelderm®

 

​

3

 

​

1,600

 

​

(1,600)

​

 

—

Accutane®

 

​

5

 

​

4,727

 

​

(1,970)

​

 

2,757

Amzeeq®

 

​

9

 

​

15,162

 

​

(1,995)

​

 

13,167

Zilxi®

 

​

6

 

​

3,760

 

​

(895)

​

 

2,865

​

 

​

​

 

​

33,983

 

​

(11,797)

​

​

22,186

Non-amortizable intangible assets:

 

​

​

 

​

  

 

​

  

​

 

  

Anti-itch product (1)

 

​

3

 

​

3,942

 

​

—

​

 

3,942

​

​

​

​

​

​

​

​

​

​

​

​

​

Total intangible assets

​

​

​

​

$

37,925

​

$

(11,797)

​

$

26,128

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

    

December 31, 2022

​

​

Estimated

​

​

​

​

​

​

​

​

​

​

​

Useful

​

Gross

​

​

​

​

​

​

​

Lives

​

Carrying

​

Accumulated

​

Intangible

($’s in thousands)

    

(Years)

    

Value

    

Amortization

    

Assets, Net

Amortizable intangible assets:

​

  

​

​

  

​

​

  

​

​

​

  

Ceracade®

​

​

3

​

$

300

​

$

(300)

​

$

—

Luxamend®

 

​

3

 

​

50

 

​

(50)

​

 

—

Targadox®

 

​

3

 

​

1,250

 

​

(1,250)

​

 

—

Ximino®

​

​

7

​

​

7,134

​

​

(3,482)

​

​

3,652

Exelderm®

​

​

3

​

​

1,600

​

​

(1,600)

​

​

—

Accutane®

 

​

5

 

​

4,727

 

​

(1,733)

​

 

2,994

Amzeeq®

 

​

9

 

​

15,162

 

​

(1,597)

​

 

13,565

Zilxi®

 

​

6

 

​

3,760

 

​

(716)

​

 

3,044

​

 

​

​

 

​

33,983

 

​

(10,728)

​

​

23,255

Non-amortizable intangible assets:

 

​

  

 

​

  

 

​

​

​

 

  

Anti-itch product (1)

 

​

3

 

​

3,942

 

​

—

​

 

3,942

​

​

​

​

​

​

​

​

​

​

​

​

​

Total intangible assets

​

​

​

​

$

37,925

​

$

(10,728)

​

$

27,197

(1) As of March 31, 2023, this asset has not yet been placed in service, therefore no amortization expense was recognized on this asset for the period ended March 31, 2023.
Schedule of future amortization of intangible assets

​

​

​

​

​

$’s in thousands

    

Total Amortization

Remainder of 2023

​

$

3,207

December 31, 2024

​

​

4,277

December 31, 2025

​

 

4,277

December 31, 2026

​

 

3,064

December 31, 2027

​

 

1,775

Thereafter

​

 

5,586

Subtotal

​

​

22,186

Asset not yet placed in service

​

 

3,942

Total

​

$

26,128